CP110 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.548800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.816400E-01
Normal-vs-Stage2
7.299400E-01
Normal-vs-Stage3
2.976400E-02
Normal-vs-Stage4
3.867800E-01
Stage1-vs-Stage2
7.219400E-01
Stage1-vs-Stage3
3.425700E-02
Stage1-vs-Stage4
5.455200E-01
Stage2-vs-Stage3
4.67659999614511E-08
Stage2-vs-Stage4
2.341400E-01
Stage3-vs-Stage4
1.037980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.571800E-01
Normal-vs-AfricanAmerican
3.971600E-01
Normal-vs-Asian
6.658600E-01
Caucasian-vs-AfricanAmerican
3.909800E-01
Caucasian-vs-Asian
2.281400E-01
AfricanAmerican-vs-Asian
8.750300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.437400E-01
Normal-vs-Female
7.647600E-01
Male-vs-Female
8.864800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.243200E-01
Normal-vs-Age(41-60Yrs)
4.976200E-01
Normal-vs-Age(61-80Yrs)
8.276200E-01
Normal-vs-Age(81-100Yrs)
4.293600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.379200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.841600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.001200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.219960E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.129900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.991900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.524400E-01
Normal-vs-Daily Drinker
9.910200E-01
Normal-vs-Weekly Drinker
8.717000E-01
Normal-vs-Occasional Drinker
6.292200E-01
Normal-vs-Social Drinker
5.385600E-01
Non Drinker-vs-Daily Drinker
9.383600E-01
Non Drinker-vs-Weekly Drinker
6.526600E-01
Non Drinker-vs-Occasional Drinker
2.089200E-01
Non Drinker-vs-Social Drinker
1.745190E-01
Daily Drinker-vs-Weekly Drinker
7.738600E-01
Daily Drinker-vs-Occasional Drinker
3.532400E-01
Daily Drinker-vs-Social Drinker
2.249400E-01
Weekly Drinker-vs-Occasional Drinker
5.527800E-01
Weekly Drinker-vs-Social Drinker
3.765800E-01
Occasional Drinker-vs-Social Drinker
7.057600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.879500E-02
Normal-vs-Grade 2
2.046000E-02
Normal-vs-Grade 3
3.784400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.452970E-01
Grade 1-vs-Grade 3
5.708300E-02
Grade 1-vs-Grade 4
8.879500E-02
Grade 2-vs-Grade 3
2.636400E-01
Grade 2-vs-Grade 4
2.046000E-02
Grade 3-vs-Grade 4
3.784400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.533200E-01
Normal-vs-NonDiabetic
8.078000E-01
Diabetic-vs-NonDiabetic
3.476800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.431000E-01
Normal-vs-NoPancreatitis
8.547800E-01
Pancreatitis-vs-NoPancreatitis
8.028800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.135400E-01
Normal-vs-N1
7.484000E-01
N0-vs-N1
6.796600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.403800E-01
Normal-vs-TP53-NonMutant
7.115600E-01
TP53-Mutant-vs-TP53-NonMutant
7.701800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
